Used in pharmaceutical research as a potent and selective inhibitor of specific kinase enzymes involved in inflammatory and oncogenic signaling pathways. Shows promise in the development of targeted therapies for certain cancers, particularly those driven by dysregulated tyrosine kinase activity. Its structure enables high binding affinity to ATP-binding sites of target kinases, enhancing cellular potency and selectivity. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved metabolic stability and oral bioavailability. Investigated for potential use in treating neurodegenerative conditions due to its ability to cross the blood-brain barrier and modulate central nervous system targets.